Mutations in Heart Sarcomas
Author Information
Author(s): Garcia J M, Gonzalez R, Silva J M, Dominguez G, Vegazo I S, Gamallo C, Provencio M, España P, Bonilla F
Primary Institution: Clinica Puerta de Hierro, Madrid, Spain
Hypothesis
Are there mutations in the K-ras and TP53 genes in primary sarcomas of the heart?
Conclusion
The study found that 60% of patients with cardiac sarcomas had a specific mutation in the K-ras gene, but no mutations were found in the TP53 gene.
Supporting Evidence
- No point mutations were observed in the p53 gene in any of the five cases.
- Three patients (60%) presented the same mutation at the first base of codon 13 (G to A transition) in the K-ras gene.
Takeaway
The researchers looked at heart tumors and found that some had a specific change in a gene called K-ras, but none had changes in another gene called TP53.
Methodology
The study investigated mutations in the p53 and K-ras genes in five patients with cardiac sarcomas.
Participant Demographics
Three patients with cardiac angiosarcomas and two with cardiac rhabdomyosarcomas.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website